Dulaglutide exerts beneficial anti atherosclerotic effects in ApoE knockout mice with diabetes: the earlier, the better

There has been no report about the mechanism for anti-atherosclerotic effects of dulaglutide (Dula) and/or about the difference of its effectiveness between in an early and a late phase of diabetes. To address such questions, streptozotocin (STZ) was intraperitoneally injected to ApoE knockout mice...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanada, Junpei, Obata, Atsushi, Obata, Yoshiyuki, Fushimi, Yoshiro, Shimoda, Masashi, Kohara, Kenji, Nakanishi, Shuhei, Mune, Tomoatsu, Kaku, Kohei, Kaneto, Hideaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809053/
https://www.ncbi.nlm.nih.gov/pubmed/33446799
http://dx.doi.org/10.1038/s41598-020-80894-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809053/
https://www.ncbi.nlm.nih.gov/pubmed/33446799
http://dx.doi.org/10.1038/s41598-020-80894-x

Ejemplares similares